| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8862 |
| Human Intestinal Absorption | HIA+ | 0.9901 |
| Caco-2 Permeability | Caco2+ | 0.8585 |
| P-glycoprotein Substrate | Non-substrate | 0.7563 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9376 |
| Non-inhibitor | 0.9634 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8306 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5888 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7426 |
| CYP450 2D6 Substrate | Non-substrate | 0.7087 |
| CYP450 3A4 Substrate | Non-substrate | 0.5427 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7171 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9653 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7228 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8849 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9423 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9068 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9183 |
| Non-inhibitor | 0.8657 |
| AMES Toxicity | Non AMES toxic | 0.7941 |
| Carcinogens | Non-carcinogens | 0.5181 |
| Fish Toxicity | Low FHMT | 0.7121 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8684 |
| Honey Bee Toxicity | High HBT | 0.5258 |
| Biodegradation | Not ready biodegradable | 0.9096 |
| Acute Oral Toxicity | III | 0.4831 |
| Carcinogenicity (Three-class) | Non-required | 0.6005 |